Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet — manufactured by Trumac Healthcare

Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Cefuroxime 250 mg + Clavulanic Acid 125 mg
Form: Tablet
Class: Second-Gen Cephalosporin + Beta-Lactamase Inhibitor
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Cefob-CV 250 Tablet

Cefob-CV 250 Tablet

Pack: 10 x 1 x 10 (Alu-Alu)

MRP: ₹4500

View Cefob-CV 250 Tablet →

Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Cefuroxime 250 mg + Clavulanic Acid 125 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Beta-lactamase-producing bacterial infections
  • Acute sinusitis with prior antibiotic failure
  • Acute otitis media
  • Lower respiratory tract infections
  • Skin and soft-tissue infections
  • Animal/human bite wound infections
Mechanism of Action

Cefuroxime is a second-generation cephalosporin that binds penicillin-binding proteins, inhibiting peptidoglycan cross-linking and producing bacterial cell wall destabilisation. Compared with first-generation cephalosporins, cefuroxime has enhanced gram-negative activity (H. influenzae, M. catarrhalis, E. coli) plus retained gram-positive coverage. Clavulanic acid is a suicide-substrate beta-lactamase inhibitor that protects cefuroxime from enzymatic destruction.

Dosage & Administration
  • Adults: 1 tablet twice daily for 7–10 days.
  • Take with food.
Side Effects
  • Diarrhoea, nausea, vomiting, mild skin rash.
  • Rare: pseudomembranous colitis, anaphylaxis, severe skin reactions, transient hepatic enzyme elevation.
  • Cross-reactivity with penicillin allergy (~5–10%).
  • Increased GI upset and diarrhoea due to clavulanate.
Contraindications
  • Hypersensitivity to cephalosporins.
  • Severe penicillin allergy.
  • Caution in renal impairment (dose adjustment).
  • Caution in GI disease.
  • History of cholestatic jaundice with clavulanate.
Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise for Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 10 x 1 x 10 (Alu-Alu)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet?

Available pack sizes include: 10 x 1 x 10 (Alu-Alu).

What is the MRP / trade price for Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet?

MRPs range from ₹4500 to ₹4500 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Cefuroxime 250 mg + Clavulanic Acid 125 mg Tablet?

Get Pricing & Franchise Terms →